KD Logo

The Potential Rise in the Price of Tandem Diabetes Care Inc (TNDM) following insiders activity

Tandem Diabetes Care Inc’s filing revealed that its Director Allen Dick unloaded Company’s shares for reported $0.26 million on May 30 ’24. In the deal valued at $51.68 per share,5,000 shares were sold. As a result of this transaction, Allen Dick now holds 0 shares worth roughly $0.0.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Allen Dick bought 5,000 shares, generating $94,778 in total proceeds. Upon buying the shares at $18.96, the Director now owns 19,962 shares.

Before that, Vosseller Leigh bought 6,200 shares. Tandem Diabetes Care Inc shares valued at $95,395 were divested by the EVP & CHIEF FINANCIAL OFFICER at a price of $15.39 per share. As a result of the transaction, Vosseller Leigh now holds 11,860 shares, worth roughly $0.46 million.

Redburn Atlantic initiated its Tandem Diabetes Care Inc [TNDM] rating to a Buy in a research note published on May 30, 2024; the price target was $60. A number of analysts have revised their coverage, including Citigroup’s analysts, who increased its forecast for the stock in late May from “a Neutral” to “a Buy”. Wells Fargo also remained covering TNDM and has increased its forecast on April 29, 2024 with a “an Overweight” recommendation from previously “an Equal weight” rating. Leerink Partners revised its rating on April 25, 2024. It rated TNDM as “an Outperform” which previously was an “a Market perform”.

Price Performance Review of TNDM

On Tuesday, Tandem Diabetes Care Inc [NASDAQ:TNDM] saw its stock fall -0.76% to $39.15. Over the last five days, the stock has lost -2.49%. Tandem Diabetes Care Inc shares have risen nearly 32.35% since the year began. Nevertheless, the stocks have risen 59.54% over the past one year. While a 52-week high of $53.69 was reached on 05/31/24, a 52-week low of $13.82 was recorded on 01/31/24. SMA at 50 days reached $44.20, while 200 days put it at $29.41. A total of 1.29 million shares were traded, compared to the trading of 1.5 million shares in the previous session.

Levels Of Support And Resistance For TNDM Stock

The 24-hour chart illustrates a support level at 38.54, which if violated will result in even more drops to 37.94. On the upside, there is a resistance level at 39.79. A further resistance level may holdings at 40.43. The Relative Strength Index (RSI) on the 14-day chart is 30.82, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.47, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.83%. Stochastics%K at 7.99% indicates the stock is a buying.

Most Popular